• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Synergy Disc® Reaches 100 U.S. Cases in 100 Days Following FDA Approval, Advancing Motion-Preserving Cervical Disc Replacement in the U.S.

July 21, 2026 By SPINEMarketGroup

Following FDA approval earlier this year, U.S. surgeons are adopting the Synergy Disc ® for its motion-preserving design, 6-degree lordotic core, and nickel-free titanium alloy.

  • The Synergy Disc reached 100 U.S. cervical disc replacement cases within 100 days of its first commercial U.S. procedure, reflecting early surgeon adoption of a motion-preserving alternative to traditional fusion.
  • The Synergy Disc is the first and only artificial cervical disc intentionally designed to preserve motion while improving anatomic alignment with its unique 6-degree lordotic core.
  • Built from time-tested orthopedic materials, including a nickel-free titanium alloy, the Synergy Disc is designed to support reliable procedures, clear postoperative imaging, and broader access for patients with nickel sensitivities.

LOUISVILLE, Colo., July 21, 2026 /PRNewswire/ — Synergy Spine Solutions®, a medical device company focused on improving the quality of life for patients undergoing spine surgery, announced today that its Synergy Disc® has been used successfully in 100 cervical disc replacement surgeries in the United States following FDA approval earlier this year.

The milestone reflects widespread surgeon adoption of the Synergy Disc, the first and only artificial cervical disc designed to intentionally preserve motion while improving anatomic alignment. The device features a unique 6-degree lordotic core to restore the spine’s natural curve and is made from a nickel-free titanium alloy, helping reduce a potential barrier for patients with nickel sensitivities or allergies. Nickel allergy is among the most common metal allergies, with published estimates suggesting that up to 17% of women and 3% of men are allergic to nickel.

“For years, our focus has been on preserving motion because that is fundamental to healthy cervical spine function,” said Dr. Todd Lanman, a spinal neurosurgeon who participated in the Synergy Disc (1-Level) IDE trial and performed the first commercial Synergy Disc procedure in the United States. “As cervical disc replacement continues to evolve, we’re also recognizing the importance of restoring cervical alignment. Synergy combines motion preservation with alignment restoration to better replicate the spine’s natural biomechanics.”

Before receiving approval for use in the United States, the Synergy Disc had been used for more than 10 years across more than 10 countries and implanted in thousands of patients. Clinical data from the company’s U.S. Investigational Device Exemption study showed that the Synergy Disc achieved an 87.1% composite clinical success rate at 24 months, demonstrating superiority to anterior cervical discectomy and fusion, a long-standing traditional treatment for cervical degenerative disc disease. Patients treated with the Synergy Disc also reported lower neck and arm pain scores and higher overall satisfaction compared to the ACDF control group.

“The clinical data behind the Synergy Disc supports what is intuitive to surgeons: cervical disc replacement must preserve motion while also restoring alignment,” said Neil Duggal, MD, Chief Medical Officer of Synergy Spine Solutions. “As more surgeons evaluate cervical disc replacement options, alignment is becoming a central part of the conversation.”

Across the 100 procedures in the U.S., surgeons voluntarily selected the 6-degree lordotic core option in 98% of cases. This strong surgeon preference reinforces the clinical importance of restoring alignment in addition to preserving motion. Earlier this year, the Synergy Disc received FDA Premarket Approval for 1-level indications at C3-C7.

Developed in close collaboration with spine surgeons, the Synergy Disc is built from time-tested orthopedic materials chosen to make procedures as safe, predictable, and reliable as possible. The device reflects a patient-first philosophy prioritizing surgical consistency, clear MRI-compatible postoperative imaging, and helping patients reclaim their quality of life.

“Reaching 100 U.S. cases within 100 days of our first commercial procedure reflects the strong early adoption of our technology and the growing demand among surgeons for cervical disc replacement solutions designed to support both motion and alignment,” said Troy Wahlenmaier, Chief Commercial Officer of Synergy Spine Solutions. “Our focus remains on scaling thoughtfully – supporting surgeons throughout the rollout while expanding access to a technology backed by more than a decade of international clinical experience.”

For more information, visit https://synergyspinesolutions.com/.

About Synergy Spine Solutions
Synergy Spine Solutions® is a medical device company focused on improving the quality of life for patients undergoing spine surgery. The company develops motion-preserving technologies designed to treat degenerative disc disease while supporting the spine’s natural curvature. Its flagship product, the FDA-approved Synergy Disc®, features a built-in 6-degree lordotic core designed to not only preserve motion but also improve sagittal alignment.

Media Contact:
AM Public Relations for Synergy Spine Solutions
synergy@ampublicrelations.com

SOURCE Synergy Spine Solutions

Related Posts:

  • Synergy Disc Replacement, Inc. (SDRI)
  • Synergy Spine Solutions® Receives FDA Approval for…
  • Synergy Cervical Disc

Filed Under: NEWS Tagged With: 2026

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical: Stronger in Spine, but Could DePuy…
  • Is DePuy Back in the Spine Fight? Why DePuy Really…
  • BROCHURES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Highridge Medical CEO Departure: Spine’s…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • Strong Surgery, Soft Quarter: ATEC and the Cost of…
  • COMPANIES
  • Autonomous Pedicle Screw Placement: Is Spine…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • The Giant Next Door: Is Mindray Spine’s Next…
  • DePuy Synthes Acquires Expanding Innovations™
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • VB Spine Announces VB Spine Solutions, a…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Johnson & Johnson Explores Potential $20B Sale…
  • What Is Medtronic’s PILAR™ Technique?
  • Percutaneous MIS Spine Systems: Why Adoption Still…
  • Who Is PAULA, and Why Should Every Deformity Surgeon…
  • Orthopedics Is Moving Into Pain. Zimmer and Globus…
  • Globus Medical Reports First Quarter 2026 Results
  • L&K Spine Performs First U.S. Deformity Case…
  • ProFlex Spine: Can a Nitinol Implant Crack…
  • VB Spine Signs Master Agreement with Apolo Medica
  • LAST 5 VIDEOS PUBLISHED

    1. Mighty Oak: Acorn 3D™
    2. Syntropiq: Lyra
    3. ATEC Spine: SafeOp®
    4. REACH Medical: Expandable PLIF/TLIF Cage
    5. Expanding Innovations: X-PAC®TLIF 

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup